Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1164447 | 1.00 | TRPA1 (0.34) | TRPA1TRPM8 | |
| SCHEMBL29350756 | 1.00 | TRPA1 (0.34) | TRPA1TRPM8 | |
| SCHEMBL7979 | 0.91 | TRPA1 (0.39) | TRPA1TRPM8 | |
| SCHEMBL1760669 | 0.91 | TRPA1 (0.39) | TRPA1TRPM8 | |
| SCHEMBL452781 | 0.91 | TRPA1 (0.39) | TRPA1TRPM8 | |
| Hydrochloric Acid SCHEMBL6863594 | 0.88 | TRPA1 (0.37) | TRPA1TRPM8 | |
| Ammonia Solution, Strong SCHEMBL5944185 | 0.88 | TRPA1 (0.37) | TRPA1TRPM8 | |
| Charcoal, Activated SCHEMBL4530459 | 0.88 | TRPA1 (0.37) | TRPA1TRPM8 | |
| Water SCHEMBL2851760 | 0.88 | TRPA1 (0.37) | TRPA1TRPM8 | |
| SCHEMBL38654752 | 0.88 | TRPA1 (0.37) | TRPA1TRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250177456-A1 | METHOD AND COMPOSITION FOR PREVENTING AND/OR TREATING METABOLIC DISORDERS | UNIV SHANDONG (CN) | 2025-06-05 | — | — | US | disclosed |
| US-20240417261-A1 | SINGLE WALLED CARBON NANOTUBE-BASED SLURRY FOR IMPROVED NUCLEAR FUEL CLADDING COATINGS AND METHOD OF FABRICATION OF SAME | ATOMIC ENERGY OF CANADA LIMITED/ÉNERGIE ATOMIQUE DU CANADA LIMITÉE (CA) | 2024-12-19 | — | — | US | disclosed |
| US-11932540-B2 | Single walled carbon nanotube-based slurry for improved nuclear fuel cladding coatings and method of fabrication of same | ATOMIC ENERGY OF CANADA LIMITED/ÈNERGIE ATOMIQUE DU CANADA LIMITÈE (CA) | 2024-03-19 | — | — | US | disclosed |
| US-11851602-B2 | Epoxide and fluorinated epoxide stabilizers for fluoroolefins | THE CHEMOURS COMPANY FC, LLC (US) | 2023-12-26 | — | — | US | disclosed |
| US-20210380859-A1 | EPOXIDE AND FLUORINATED EPOXIDE STABILIZERS FOR FLUOROOLEFINS | THE CHEMOURS COMPANY FC, LLC (US) | 2021-12-09 | — | — | US | disclosed |
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-11-18 | — | — | US | disclosed |
| US-11130894-B2 | Epoxide and fluorinated epoxide stabilizers for fluoroolefins | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-28 | — | — | US | disclosed |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-09-21 | — | — | US | disclosed |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | THE CHEMOURS COMPANY FC, LLC (US) | 2021-07-08 | — | — | US | disclosed |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | THE CHEMOURS COMPANY FC, LLC (US) | 2021-06-29 | — | — | US | disclosed |
| US-20070108403-A1 | refrigerants as heat exchanger; comprising 1,1,1,4,4,5,5,5-octafluoro-2-pentene mixture | E. I. DU PONT DE NEMOURS AND COMPANY | 2007-05-17 | — | — | US | disclosed |
| WO-2007053697-A2 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-05-10 | — | — | WO | disclosed |
| EP-1353926-B1 | MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES | SOD CONSEILS RECH APPLIC (FR) | 2006-03-08 | — | — | EP | disclosed |
| US-6887869-B2 | Mikanolide derivatives, their preparation and therapeutic uses | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2005-05-03 | — | — | US | disclosed |
| EP-1438039-A2 | PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2004-07-21 | — | — | EP | disclosed |
| US-20040138245-A1 | Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2004-07-15 | — | — | US | disclosed |
| US-20040122084-A1 | Mikanolide derivatives, their preparation and therapeutic uses | IPSEN PHARMA S.A.S. (FR) | 2004-06-24 | — | — | US | disclosed |
| EP-1353926-A1 | MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES | Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) (FR) | 2003-10-22 | — | — | EP | disclosed |
| WO-2002096348-A2 | PRODUCT COMPRISING MIKANOLIDE, DIHYDROMIKANOLIDE OR AN ANALOGUE THEREOF COMBINED WITH ANOTHER ANTI-CANCER AGENT FOR THERAPEUTIC USE IN CANCER TREATMENT | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-12-05 | — | — | WO | disclosed |
| WO-2002055523-A1 | MIKANOLIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USES | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 2002-07-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250177456-A1 | METHOD AND COMPOSITION FOR PREVENTING AND/OR TREATING METABOLIC DISORDERS | LIPC, GYS2, PNLIP | TRPA1 4441/4885TRPM8 4240/4885 |
| US-20210355360-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | TRPA1 306/4885TRPM8 2387/4885 |
| US-20040122084-A1 | Mikanolide derivatives, their preparation and therapeutic uses | MSR1, GSR, OGFR | TRPA1 4685/4885TRPM8 3381/4885 |
| US-20040138245-A1 | Product comprising mikanolide, dihydromikanolide or an analogue thereof combine with another anti-cancer agent for therapeutic use in cancer treatment | DTYMK, DGKG, DGKZ | TRPA1 3308/4885TRPM8 1398/4885 |
| US-11046877-B1 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | TRPA1 306/4885TRPM8 2387/4885 |
| US-20210207014-A1 | COMPOSITIONS COMPRISING FLUOROOLEFINS AND USES THEREOF | GFPT1, PFAS, TRMT1 | TRPA1 306/4885TRPM8 2387/4885 |
| US-11124685-B2 | Compositions comprising fluoroolefins and uses thereof | GFPT1, PFAS, TRMT1 | TRPA1 306/4885TRPM8 2387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.